Keyword: Eli Lilly

News

Lilly Working to Increase Enrollment of Diverse Populations in Clinical Trials

21.09.2011 - Eli Lilly announced findings from a prospectively designed observational study that resulted in new ways to increase minority participation in clinical trials. As part of Lilly's...

News

EU Clears Eli Lilly To Buy J&J Animal Health Unit

07.07.2011 - U.S. drugmaker Eli Lilly & Co secured European Union regulatory approval on Thursday to buy Johnson & Johnson's animal health unit Janssen to boost its presence in Europe. The...

News

Amylin Sues Lilly over Diabetes Partnership

17.05.2011 - Amylin Pharmaceuticals is suing longtime diabetes-drug partner Eli Lilly over its plans to help market a rival product with another company. Lilly helps the smaller Amylin sell the...

News

Roche Seen Kicking off Q1 Season With Sales Drop

14.04.2011 - Roche is poised to kick off the Big Pharma reporting season with a drop in sales due to weaker demand for top-selling Avastin and flu drug Tamiflu and governments' drive to cut...

News

British Man Jailed After Record Fake Medicine Bust

11.04.2011 - A British man was jailed for eight years on Friday for his role in supplying more than 2 million doses of fake medicines in the most serious known case of counterfeit drugs getting...

Strategy & Management

Oracle’s Agile PLM Reorganizes Pharma, From Lab to Launch

26.01.2011 - Becoming Nimble - It's no secret that Big Pharma is facing some of the biggest changes in the history of the industry. The looming patent cliff is now forcing companies to...

Plant Construction & Process Technology

Patent Cliff To Intensify in the U.S. in 2011

21.01.2011 - Pressures on the U.S. pharmaceutical industry has built over the past few years, stemming from an increasingly stringent drug regulatory environment and the global economic...

News

Eli Lilly, Boehringer Ingelheim in Drug-Development Alliance

12.01.2011 - Eli Lilly struck a drug-development alliance with Germany's Boehringer Ingelheim as the U.S drugmaker tries to revive its diabetes business after setbacks and help it maneuver past...